Results 191 to 200 of about 45,555 (245)
Deep learning and radiomics models in patients with advanced non-small cell lung cancer treated with immunotherapy combined with stereotactic radiotherapy. [PDF]
Kothari G +13 more
europepmc +1 more source
Fractionated Stereotactic Radiotherapy to Resection Cavities Following Brain Metastasis Surgery: Clinical Outcomes and Challenges. [PDF]
Windisch P +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Implementation of Stereotactic Ablative Radiotherapy (Stereotactic Body Radiotherapy)
Clinical Oncology, 2012The National Radiotherapy Implementation Group report, Guidelines for commissioners, providers and clinicians in England 2011, on stereotactic body radiotherapy (SBRT) [1] defined SBRT as ‘the precise irradiation of an image defined extra cranial lesion associated with the use of high radiation dose delivered in a small number of fractions’. Previously,
P, Kirkbride, P J, Hoskin
openaire +2 more sources
Stereotactic Body Radiotherapy
Clinical Oncology, 2015Stereotactic body radiotherapy (SBRT), which is also referred to as stereotactic ablative radiotherapy (SABR) and extra-cranial stereotactic radiosurgery, has been rapidly diffusing into clinical practice [1,2]. Over the last few years it has become established as an out-patient, nonor minimally invasive treatment option for certain clinical ...
Dahele, M.R., McLaren, D.B.
openaire +4 more sources
Stereotactic Body Radiotherapy
Seminars in Oncology, 2014Extracranial stereotactic body radiotherapy (SBRT) has been developed and refined over the last 25 years as a means to precisely deliver ablative doses of hypofractionated radiotherapy to small targets located outside of the cranial vault. SBRT has armed the radiation oncologist with a therapeutic approach that allows for intensification of both dose ...
Laura, Kollar, Ramesh, Rengan
openaire +2 more sources
Stereotactic Radiotherapy for Pulmonary Metastases
Seminars in Thoracic and Cardiovascular Surgery, 2013The most common treatment of pulmonary metastasis for solid tumors employs systemic chemotherapy, hormonal therapy, or biologic agents. Some series have suggested that aggressive surgical resection of pulmonary metastasis may improve patient outcomes in terms of quality of life and overall survival. Recently, data from clinical trials and retrospective
Steven J, Chmura +2 more
openaire +2 more sources

